Sale!

RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test

Original price was: ₦ 560,000.Current price is: ₦ 400,000.

-29%

The RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic mutations associated with primary ciliary dyskinesia. This test is vital for patients exhibiting symptoms related to respiratory and ENT disorders. Priced at 400000 NGN, it offers insights into genetic predispositions affecting ciliary function, aiding in better clinical management and treatment decisions.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 08077798758
Guaranteed Safe Checkout

RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test

Introduction

The RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test is a state-of-the-art diagnostic tool that utilizes Next Generation Sequencing (NGS) technology to identify mutations in the RSPH9 gene associated with primary ciliary dyskinesia (PCD). This condition affects the function of cilia, which play a critical role in maintaining respiratory health and clearing mucus from the airways. Early detection of PCD is essential for effective management and treatment of the associated symptoms.

What the Test Measures

This genetic test specifically detects mutations in the RSPH9 gene. By analyzing the DNA, healthcare professionals can determine if a patient has genetic predispositions that may lead to PCD. This test is particularly important for patients with a family history of respiratory issues or those displaying symptoms related to ciliary dysfunction.

Who Should Consider This Test

  • Patients with chronic respiratory infections.
  • Individuals with a family history of primary ciliary dyskinesia.
  • Patients experiencing symptoms such as chronic cough, nasal congestion, or ear infections.
  • Individuals referred by an ENT specialist for further investigation of unexplained respiratory or ENT disorders.

Benefits of Taking the Test

  • Provides a definitive diagnosis for patients with symptoms of PCD.
  • Facilitates early intervention and tailored treatment plans.
  • Helps in understanding the genetic basis of respiratory issues, leading to better management.
  • Offers peace of mind for patients and their families through clarity on genetic risks.

Understanding Your Results

Results from the RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test will be interpreted by qualified genetic counselors and healthcare professionals. They will provide insights into the findings, explain the implications for your health, and discuss potential next steps in management or treatment based on your results.

Test Pricing

Price Type Amount (NGN)
Discount Price 400000 NGN
Regular Price 560000 NGN

Book Your Test Today!

To take the next step in understanding your health, book the RSPH9 Gene Primary Ciliary Dyskinesia Type 12 NGS Genetic DNA Test today. For inquiries or to schedule your test, please contact us via phone or WhatsApp at +2348077798758.